Shanghai Junshi Biosciences Co., Ltd.
SHJBF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.44B
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $3.44 Billion |
|---|---|
| Enterprise Value | $6.68 Billion |
| Earnings per Share | $-0.84 |
| Beta | 0.58 |
| Outstanding Shares | 1,025,874,000 |
Return
| Return on Equity | -7.21% |
|---|---|
| Return on Assets | -3.01% |
| Return on Invested Capital | -4.11% |
Valuation & Multiples
| P/E Ratio | -69.15 |
|---|---|
| PEG | 1042.67 |
| Price to Sales | 1.12 |
| Price to Book Ratio | 0.56 |
| Enterprise Value to Revenue | 2.08 |
| Enterprise Value to EBIT | -14.3 |
| Enterprise Value to Net Income | -16 |
| Total Debt to Enterprise | 0.89 |
| Debt to Equity | 1.01 |
Revenue Sources
No data
Last Earnings Call
Report Date
October 30, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateNext Earnings Call
Expected Date
April 1, 2027
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Shanghai Junshi Biosciences Co., Ltd.
3,055 employees
CEO: Cong Li
Shanghai Junshi Biosciences Co., Ltd. is a biopharmaceutical firm focused on the research, creation, and marketing of diverse pharmaceutical products. Operating within the People's Republic of China, its therapeutic focus spans oncology,...